Consist of handwritten minutes from strategy discussion regarding Gori's impending publication on health effects by cigarette brands. Notes "we are not in top 4 [on list]". Indicates Spears "not comfortable about participating [in publication] in terms of "by-line" and remarks "could have the appearance of 'conspiracy'". Logs timing of follow-up calls and speculates about alternative co-authorship possibilities.
Consists of difficult-to-read handwritten meeting notes from 10/5/76 recounting discussions regarding public relations and strategies relating to advertising restrictions and "Fairness Doctrine". Indicates federal-level contacts and lobbying should be done by Tobacco Institute and not individual companies and notes "[s]tay away from Consumer Prod[uct] Safety [Commission]. Adds we
"[w]e want to avoid appearance of association or collaboration w[ith] GG [Gio Gori]" and "get away from facts".
Consists of handwritten meeting notes regarding brand-specific advertising restrictions and unspecified press release.
Indicates "recast T&N [tar and nicotine] data on [Gio] Gori's criteria for FTC [Federal Trade Commission] brands per attachment". Notes "Stevens prefers not going that route unless [unreadable name] does & we discuss benefits". Consists of legible handwritten note (attachment missing).
Ask for position statement on "why, if the cigarette companies do not want to promote smoking among young people, they allow candy cigarette manufacturers to use their brand names". Notes "I do not know that you do 'allow' this. But what is the answer?"
Informs that Fundeberg has been approved by all General Counsel for funding as Council for Tobacco Research Special Project. Refers to previous memorandum for particulars.
Consists of difficult-to-read handwritten notes regarding federal legislation and regulations concerning youth access, secondhand smoke and related industry strategy "projects". Includes some hand-deleted notes regarding "Summary Report" on health hazards and prohibition.
Reminds Soloff "is most articulate in expressing his views on smoking and health". Indicates his three year National Institutes of Health grant in biochemistry is prestigious and "will supplement Dr. Soloff's [Council for Tobacco Research grant in atherosclerosis] so that he will be able to proceed at an accelerated pace".
Updates on three industry-sponsored projects: (1) shared funding of Soloff by Scientific Advisory Board (SAB) and Council for Tobacco Research (CTR) Special Project mechanisms; (2) CTR Special Project support for MacDonald; and (3) Proposed reallocation of funds to support Sterling. Refers to specific previous letters and requests follow-up.
Confirms Soloff's has capable enzyme chemist named Lacko. Adds Hockett "does not believe there is a problem with respect to Soloff reporting on his projects since he generally obtains early publication of his work". Infers Spears may still have questions on matter and notes additional opinions are being sought.
Informs pending conversation with Soloff at the end of the month, the letter requested will be sent.
Reviews and critiques Soloff's hypothesis regarding smoking and atherosclerosis and points out his past failure to submit progress reports to the Scientific Advisory Board (SAB) for project entitled: "Hemodynamic lipoprotein and enzymatic findings in atherosclerosis and their modification by smoking". Approves "increasing financial support to Doctor Soloff" based on particular conditions, including submission of progress reports and advance review of experimental plans. Includes notes in marginalia.
Confirms Lorillard will participate in Council for Tobaccco Research (CTR) Special Project funding for Ogura's study per Hardy's previous letters.
Quotes Banzhaf's comments from Crossfire transcript regarding future industry product liability suits and requests responses regarding Ogura project per Hardy's earlier letter.
Transmits reports from various industry and federal sources relative to health effects of smoking. Includes commentary on difficulties in establishing causal inference (attachments missing).
Confirms that Lorillard will participate in Ratcliffe's Council for Tobacco Research (CTR) Special Project funding per previous letter.
Transmits "reports on the Swedish and American Twin Studies presented in Rome, September 4-7" in view of recent publicity. Indicates no distribution or quotation should be made at author's request in that they have rights of first publication (attachments missing).
Confirms "Lorillard's agreement to participate in the funding of this [Council for Tobacco Research] Special Project relating to Dr. Olkin". Indicates two-year project will be funded at $6,000 per year, references previous correspondence and attaches memorandum "[f]or your additional information and guidance" (attachment missing).
Transmits Olkin's curriculum vitae and his proposal for Council for Tobacco Research (CTR) Special Projects funding for a project entitled "A Study of the Models Used in the Analysis of Certain Medical Data". Indicates how he intends "to examine the theoretical structure of the 'multivariate logistic risk function'", originally used in National Institutes of Health MRFIT study of heart disease in Framingham. Notes Gardner has reviewed and approved the proposal and requests feedback (attachments missing).
Indicates "[n]o problems with the genetics project agreement" (legible handwriten message).
Transmit materials edited by Spears related to unspecified project. Suggests joint review before decision is made about "what materials, if any, concerning this project, should be circulated to Messrs. Tisch and Pollack" (attachment missing).
Consists of handwritten note with projects costs for unspecified project under consideration for industry sponsorship, based on which companies might participate. Mentions "Ed Jacob's letter re[garding] review & early exit (if no progress) times - designed to prevent Harvard type situation". Includes addition notes in marginalia.
Documents for file Spears' various arguments in favor of funding genetics project, noting "it could have significant...benefits relating to statistics; would contribute toward the establishment of filial groups as valuable genetic study entities; and enhance knowledge of general non-tobacco science". Indicates possibility for "full term of ten years".
Consists of difficult-to-read handwritten notes from strategy session regarding health effects of smoking. Discusses public relations, policy concerns, and possible future research directions. States "tob[acco] is a drug".